108 related articles for article (PubMed ID: 12496488)
1. Modeling antiangiogenesis gene therapy.
Tsai JH; Lee WM
Cancer Biol Ther; 2002; 1(5):554-5. PubMed ID: 12496488
[No Abstract] [Full Text] [Related]
2. Gene therapy of prostate cancer with the soluble vascular endothelial growth factor receptor Flk1.
Becker CM; Farnebo FA; Iordanescu I; Behonick DJ; Shih MC; Dunning P; Christofferson R; Mulligan RC; Taylor GA; Kuo CJ; Zetter BR
Cancer Biol Ther; 2002; 1(5):548-53. PubMed ID: 12496487
[TBL] [Abstract][Full Text] [Related]
3. Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy.
Jin F; Xie Z; Kuo CJ; Chung LW; Hsieh CL
Cancer Gene Ther; 2005 Mar; 12(3):257-67. PubMed ID: 15565180
[TBL] [Abstract][Full Text] [Related]
4. Cover story. RNA interference (RNAi).
Park TG
J Control Release; 2008 Jul; 129(2):75. PubMed ID: 18547671
[No Abstract] [Full Text] [Related]
5. Gene therapeutic exploration: retrovirus-mediated soluble vascular endothelial growth factor receptor-2 (sFLK-1) inhibits the tumorigenicity of S180, MCF-7, and B16 cells in vivo.
Kou B; Li Y; Shi Y; Xia J; Wang X; Wu S
Oncol Res; 2005; 15(5):239-47. PubMed ID: 16261843
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor model.
Raikwar SP; Temm CJ; Raikwar NS; Kao C; Molitoris BA; Gardner TA
Mol Ther; 2005 Dec; 12(6):1091-100. PubMed ID: 16169279
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice.
Tseng JF; Farnebo FA; Kisker O; Becker CM; Kuo CJ; Folkman J; Mulligan RC
Surgery; 2002 Nov; 132(5):857-65. PubMed ID: 12464871
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.
Xu M; Xie Y; Sheng W; Miao J; Yang J
Technol Cancer Res Treat; 2015 Oct; 14(5):617-26. PubMed ID: 24750000
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin.
Chen CT; Lin J; Li Q; Phipps SS; Jakubczak JL; Stewart DA; Skripchenko Y; Forry-Schaudies S; Wood J; Schnell C; Hallenbeck PL
Hum Gene Ther; 2000 Sep; 11(14):1983-96. PubMed ID: 11020798
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
Lee J; Wang A; Hu Q; Lu S; Dong Z
Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
[TBL] [Abstract][Full Text] [Related]
11. Strategies to adapt adenoviral vectors for targeted delivery.
O'Riordan CR; Song A; Lanciotti J
Methods Mol Med; 2003; 76():89-112. PubMed ID: 12526160
[No Abstract] [Full Text] [Related]
12. Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy.
Sato M; Johnson M; Zhang L; Zhang B; Le K; Gambhir SS; Carey M; Wu L
Mol Ther; 2003 Nov; 8(5):726-37. PubMed ID: 14599805
[TBL] [Abstract][Full Text] [Related]
13. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics.
Takei Y; Kadomatsu K; Yuzawa Y; Matsuo S; Muramatsu T
Cancer Res; 2004 May; 64(10):3365-70. PubMed ID: 15150085
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic gene therapy: disruption of neovascular networks mediated by inducible caspase-9 delivered with a transcriptionally targeted adenoviral vector.
Song W; Sun Q; Dong Z; Spencer DM; Núñez G; Nör JE
Gene Ther; 2005 Feb; 12(4):320-9. PubMed ID: 15616606
[TBL] [Abstract][Full Text] [Related]
15. Cancer gene therapy: lessons learned from experiences with chemotherapy.
Morris JC
Mol Ther; 2003 Jun; 7(6):717-9. PubMed ID: 12803174
[No Abstract] [Full Text] [Related]
16. Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.
Xu M; Xie Y; Sheng W; Miao J; Yang J
Technol Cancer Res Treat; 2015 Aug; 14(4):369-78. PubMed ID: 25326586
[TBL] [Abstract][Full Text] [Related]
17. Anti‑angiogenesis gene therapy for hepatocellular carcinoma via systemic injection of mesenchymal stem cells engineered to secrete soluble Flt‑1.
Li G; Miao F; Zhu J; Chen Y
Mol Med Rep; 2017 Nov; 16(5):5799-5806. PubMed ID: 28849176
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenics meet nanotechnology.
Ruoslahti E
Cancer Cell; 2002 Aug; 2(2):97-8. PubMed ID: 12204528
[TBL] [Abstract][Full Text] [Related]
19. Eradication of therapy-resistant human prostate tumors using a cancer terminator virus.
Sarkar D; Lebedeva IV; Su ZZ; Park ES; Chatman L; Vozhilla N; Dent P; Curiel DT; Fisher PB
Cancer Res; 2007 Jun; 67(11):5434-42. PubMed ID: 17545625
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for antiangiogenesis.
Kleinman HK; Liau G
J Natl Cancer Inst; 2001 Jul; 93(13):965-7. PubMed ID: 11438554
[No Abstract] [Full Text] [Related]
[Next] [New Search]
